Patents for C12R 1 - Micro-organisms (92,025) |
---|
10/27/1994 | WO1994024282A1 A human t-cell receptor of the g-protein coupled receptor family |
10/27/1994 | WO1994024272A1 Process for purifying collagenase |
10/27/1994 | WO1994024267A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
10/27/1994 | WO1994024265A1 Microorganism of genus bacillus cereus and use thereof |
10/27/1994 | WO1994024264A1 New bacillus thuringiensis strains and their insecticidal proteins |
10/27/1994 | WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
10/27/1994 | WO1994024161A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
10/27/1994 | WO1994024159A1 Method and product for regulating cell responsiveness to external signals |
10/27/1994 | WO1994024158A1 Cellulose binding domain |
10/27/1994 | WO1994023743A1 Method and compositions for digesting tissue |
10/27/1994 | WO1994023735A1 Novel polypeptide having factor xa inhibitory activity |
10/27/1994 | WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
10/27/1994 | WO1994023594A1 Astaxanthin over-producing strains of phaffia rhodozyma, methods for their cultivation, and their use in animal feeds |
10/27/1994 | WO1994023582A1 Adenoviral vectors including dna encoding lung surfactant protein |
10/27/1994 | WO1994020631A3 Production of glycolate oxidase in methylotrophic yeast |
10/27/1994 | WO1994020617A3 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
10/27/1994 | WO1994016068A3 Allergenic proteins and peptides from dog dander and uses therefor |
10/27/1994 | WO1994010313A3 Interferon tau compositions and methods of use |
10/27/1994 | CA2161229A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
10/27/1994 | CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo |
10/27/1994 | CA2161095A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
10/27/1994 | CA2161088A1 Expression of heterologous genes according to a targeted expression profile |
10/27/1994 | CA2160697A1 Transposition kit for gene transfer in eukaryotes |
10/27/1994 | CA2160670A1 Cellulose binding domain |
10/27/1994 | CA2160564A1 Production of plastics materials from microorganisms |
10/27/1994 | CA2160548A1 Method and product for regulating cell responsiveness to external signals |
10/27/1994 | CA2160532A1 Method and compositions for digesting tissue |
10/27/1994 | CA2160451A1 Microorganism of genus bacillus cereus and use thereof |
10/27/1994 | CA2160136A1 Adenoviral vectors including dna encoding lung surfactant protein |
10/27/1994 | CA2160115A1 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
10/27/1994 | CA2159813A1 A human t-cell receptor of the g-protein coupled receptor family |
10/27/1994 | CA2159218A1 Novel polypeptide having factor xa inhibitory activity |
10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
10/27/1994 | CA2137785A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
10/26/1994 | EP0621480A2 Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood |
10/26/1994 | EP0621341A2 Monoclonal antibodies to bovine cytokines |
10/26/1994 | EP0621340A1 Product and process for the production and purification of recombinant polypeptides |
10/26/1994 | EP0621337A1 Codon optimized DNA sequence for insect toxin AaIT |
10/26/1994 | EP0620864A1 Process for immobilizing nucleic acid probes on polystyrene surfaces |
10/26/1994 | EP0620863A1 Manipulating nucleic acid sequences |
10/26/1994 | EP0620862A1 Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification |
10/26/1994 | EP0620860A1 Preparation of recombinant borrelia proteins |
10/26/1994 | EP0620854A1 Expression and purification of recombinant soluble tissue factor |
10/26/1994 | EP0620852A1 Cyclic di-guanylate metabolic enzymes |
10/26/1994 | EP0620849A1 Transgenic animal models for alzheimer's disease |
10/26/1994 | EP0620846A1 Controlling growth of filamentous microorganisms |
10/26/1994 | EP0620826A1 Tie, a novel endothelial cell receptor tyrosine kinase |
10/26/1994 | EP0486536B1 Antiviral compositions containing sulfoquinovosyl glycerol derivatives and analogs thereof |
10/26/1994 | EP0431042B1 A method of preparing an active human neutrophil chemotactic factor polypeptide |
10/26/1994 | EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
10/25/1994 | US5359135 Detection in soil, water, air by preferential affinity to monoclonal antibodies |
10/25/1994 | US5359049 DNA probe for lactobacillus delbrueckii |
10/25/1994 | US5359036 Growth hormone-like glycoproteins |
10/25/1994 | US5359034 Cysteine depleted IL-6 muteins |
10/25/1994 | US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
10/25/1994 | US5358870 Emulsification of petroleum oils and aqueous bacterial enzyme, then incubation, for selective cleavage of carbon-sulfur bonds |
10/25/1994 | US5358869 Desulfurization of coal and oils with Rhodococcus and Bacillus by aerobic metabolism |
10/25/1994 | US5358867 DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon |
10/25/1994 | US5358866 Using cytosine deaminase as marker |
10/25/1994 | US5358865 Alkaline protease from Bacillus J 20 |
10/25/1994 | US5358864 DNA which codes for fungal endoxylanase |
10/25/1994 | US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection |
10/25/1994 | US5358849 Hybridomas; culture products; radioisotope labelling; cancer screening |
10/25/1994 | CA1332719C Microbiological process for the purification and the valorization of an organic effluent containing a fermentable sugar |
10/23/1994 | CA2121096A1 Monoclonal antibodies to bovine cytokines |
10/21/1994 | CA2116261A1 Epitopic regions of pneumococcal surface protein a |
10/19/1994 | EP0620280A1 Cosmid vectors for streptomycetes genomic DNA cloning |
10/19/1994 | EP0620279A1 Preparation of functional human urokinase proteins |
10/19/1994 | EP0620277A1 Nucleic acid pharmaceuticals |
10/19/1994 | EP0620276A1 Humanised antibodies |
10/19/1994 | EP0620275A1 A bovine group I phospholipase A2 receptor |
10/19/1994 | EP0619947A1 Yeast formulation for production of baked products |
10/19/1994 | EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins |
10/19/1994 | EP0619842A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
10/19/1994 | EP0619839A1 Novel polypeptides for promoting cell attachment |
10/19/1994 | EP0619836A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
10/19/1994 | EP0590004A4 Purified chitinases and use thereof. |
10/19/1994 | EP0506780B1 Stable integration of dna in bacterial genomes |
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/18/1994 | US5356877 Methods for promoting growth using porcine growth hormone analogs |
10/18/1994 | US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof |
10/18/1994 | US5356813 Process for the desulfurization and the desalting of a fossil fuel |
10/18/1994 | US5356801 From Rhodococcus rhodochrous |
10/18/1994 | US5356798 Adding egg yolk free of lipoproteins and lipids to increase expression of proteins |
10/17/1994 | CA2121303A1 Cosmid vectors for streptomycetes genomic dna cloning |
10/17/1994 | CA2121302A1 Amphotropic virus receptor |
10/13/1994 | WO1994023070A1 RECOMBINANT α-N-ACETYLGALACTOSAMINIDASE ENZYME AND cDNA ENCODING SAID ENZYME |
10/13/1994 | WO1994023058A1 Suppressor of hiv replication and transcription |
10/13/1994 | WO1994023053A1 Protease variants |
10/13/1994 | WO1994023052A1 A method of hydrolysing cholesterol esters by using a pseudomonas fragi cholesterol esterase |
10/13/1994 | WO1994023051A1 Improved fat splitting process |
10/13/1994 | WO1994023050A1 Targeted delivery of genes encoding antisense polyribonucleotides |
10/13/1994 | WO1994023047A1 Biological control agents containing mollusc toxins |
10/13/1994 | WO1994023040A1 Methods and dna expression systems for over-expression of proteins in host cells |
10/13/1994 | WO1994023039A1 Methods for screening of substances for therapeutic activity and yeast for use therein |
10/13/1994 | WO1994023037A1 Pharmaceuticals based on papillomaviruses |
10/13/1994 | WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |